What Is Hypogonadism?
Hypogonadism is a clinical condition where the testes produce insufficient testosterone to maintain normal male physiological function. The condition affects 2-6% of adult men overall, but prevalence jumps dramatically with age — 20-40% of men over 60 develop hypogonadism, primarily due to late-onset hypogonadism (LOH), the gradual testosterone decline that begins around age 30 and accelerates after 50.1
Two distinct mechanisms drive testosterone deficiency. Primary hypogonadism originates in the testes themselves — genetic disorders, infections, trauma, or chemotherapy damage the Leydig cells that produce testosterone. Secondary hypogonadism stems from problems in the hypothalamic-pituitary-gonadal (HPG) axis, where the brain fails to signal the testes properly.2
Age-related decline accounts for most cases in men over 50. Testosterone drops roughly 1% per year after 30, but metabolic factors like obesity create a vicious cycle — excess body fat converts testosterone to estrogen and raises sex hormone-binding globulin (SHBG), further reducing bioavailable testosterone and suppressing the HPG axis.1
Diagnosis requires two fasting morning blood tests showing total testosterone below 300 ng/dL plus at least one clinical symptom such as low libido, erectile dysfunction, fatigue, or muscle loss.
Key Takeaways
Hypogonadism occurs when the testes produce insufficient testosterone, affecting 2-6% of adult men overall but 20-40% of men over 60. Diagnosis requires two morning blood tests showing total testosterone below 300 ng/dL plus clinical symptoms like low libido, erectile dysfunction, fatigue, or muscle loss. Testosterone replacement therapy effectively improves sexual function, energy, muscle mass, and bone density in symptomatic men.
- Testosterone naturally declines about 1% per year after age 30
- Primary hypogonadism stems from testicular damage; secondary from brain signaling problems
- Morning fasting blood draws (7-10 AM) ensure accurate testosterone measurement
- Most men notice libido and energy improvements within 3-6 weeks of TRT
- Obesity creates a vicious cycle by converting testosterone to estrogen
- Fertility-preserving options like hCG exist for men wanting to conceive
Signs and Symptoms
Testosterone deficiency manifests across multiple organ systems, with symptoms varying in severity based on how low levels drop and how quickly decline occurs.
Low Libido & Erectile Dysfunction
Reduced sexual desire, fewer spontaneous erections, and difficulty achieving or maintaining erections during sexual activity.
Fatigue & Low Energy
Persistent tiredness unrelieved by rest, decreased motivation, and reduced physical stamina for daily activities.
Muscle Loss & Weakness
Declining lean muscle mass, reduced strength in resistance activities, and increased body fat despite unchanged diet.
Mood Changes & Depression
Irritability, difficulty concentrating, memory problems, and persistent low mood or depressive symptoms.
Symptom progression follows a predictable timeline in age-related decline. Sexual symptoms typically appear first — most men notice reduced libido and fewer morning erections before other changes become apparent. Energy and mood shifts follow within months, while physical changes like muscle loss and fat redistribution take 1-2 years to become clinically significant.
Severity correlates roughly with testosterone levels. Men with total testosterone in the 200-300 ng/dL range often report subtle sexual and energy changes. Those below 200 ng/dL typically experience multiple overlapping symptoms that interfere with daily function. Men with testosterone under 150 ng/dL may also develop gynecomastia (breast tissue growth), hot flashes, anemia, and progressive bone density loss increasing fracture risk.1
Not every man with low testosterone experiences all symptoms. Individual androgen receptor sensitivity varies, and some men with borderline-low levels (280-320 ng/dL) report significant symptoms while others at similar levels feel normal. That's why diagnosis requires both biochemical confirmation and clinical symptoms — treating the lab value alone isn't the goal.
Androgen Receptor Sensitivity refers to the varying biological responsiveness of cells to testosterone and other androgens, determined by the number and function of androgen receptors. This individual variation explains why men with similar testosterone levels experience different symptom severities.
Gynecomastia is the abnormal enlargement of male breast tissue, occurring when testosterone levels drop significantly and the estrogen-to-testosterone ratio becomes elevated, disrupting normal hormonal balance in breast tissue.
What Causes Hypogonadism
Testosterone deficiency arises from direct testicular damage, failure in the brain's signaling system, or age-related metabolic decline. Understanding which mechanism is active guides treatment approach.
Primary Testicular Failure
Klinefelter syndrome (extra X chromosome impairing Leydig cell function) is the most common genetic cause. Acquired damage from mumps orchitis, testicular trauma, radiation, chemotherapy, or hemochromatosis destroys testosterone-producing cells directly. Lab tests show elevated LH and FSH as the pituitary tries to compensate for low testosterone output.1
Secondary/Central Defects
Kallmann syndrome (congenital GnRH deficiency with loss of smell) represents the classic inherited form. Pituitary tumors like prolactinomas, craniopharyngiomas, or damage from head trauma and infiltrative diseases disrupt LH and FSH production. The testes remain structurally normal but receive inadequate signals. Labs show low or inappropriately normal LH/FSH alongside low testosterone.3
Age-Related & Metabolic
Testosterone drops about 1% per year after age 30, accelerating in men with obesity or type 2 diabetes. Excess body fat drives aromatase enzyme activity, converting testosterone to estradiol and creating a feedback loop that suppresses the HPG axis. Rising SHBG levels with age bind more testosterone, reducing the bioavailable fraction that enters cells. This bidirectional obesity-testosterone interaction explains why weight loss alone can raise levels 50-100 ng/dL in overweight men.1
The HPG axis operates through a tightly regulated feedback loop. The hypothalamus releases GnRH in pulses, stimulating the pituitary to secrete LH and FSH. LH acts on testicular Leydig cells to produce testosterone, while FSH supports sperm production in Sertoli cells. Testosterone feeds back to inhibit GnRH and LH release, maintaining homeostasis.2 Disruption at any level — hypothalamus, pituitary, or testes — breaks this cycle and causes testosterone deficiency.
Diagnosis and Lab Tests
Total Testosterone
Below 300 ng/dL on two separate tests
LH/FSH Levels
Distinguishes primary from secondary causes
Morning Fasting Sample
Collected between 7-10 AM for accuracy
Symptoms Required
Low lab value plus clinical signs
Formal diagnosis requires two morning fasting blood draws showing total testosterone below 300 ng/dL (some guidelines use 264 ng/dL as the threshold) plus at least one clinical symptom — reduced libido, erectile dysfunction, fatigue, or muscle loss.1 Morning timing matters because testosterone peaks 7-10 AM and declines through the day, so afternoon samples can give falsely low results.
Reference ranges for key labs: total testosterone 300-1000 ng/dL, free testosterone 50-210 pg/mL, LH 1.5-9.3 IU/L, FSH 1.4-18.1 IU/L. Elevated LH and FSH with low testosterone signals primary testicular failure — the pituitary is trying to compensate. Low or inappropriately normal LH/FSH alongside low testosterone indicates secondary hypogonadism, where the problem lies in the brain's signaling system.1
Additional labs help rule out other causes and assess treatment safety. Prolactin screens for pituitary tumors. SHBG and calculated free testosterone clarify bioavailable hormone levels. Complete blood count checks for anemia. PSA baseline is mandatory before starting TRT in men over 40. Semen analysis becomes relevant for men concerned about fertility.
Validated screening questionnaires like the Androgen Deficiency in the Aging Male (ADAM) or Aging Males' Symptoms (AMS) scale identify men who warrant lab testing, but they can't replace biochemical confirmation.4 Depression, sleep apnea, thyroid dysfunction, chronic liver or kidney disease, HIV, and medications like opioids or glucocorticoids all mimic hypogonadism symptoms and require exclusion.2
The critical point: labs must match symptoms. Treating a number without clinical correlation leads to unnecessary therapy and missed alternative diagnoses.
Treatment and Management
Testosterone Replacement Therapy
TRT is the primary treatment for symptomatic hypogonadism, with strong randomized trial evidence showing improvements in libido, erectile function, muscle mass, bone density, mood, and energy.1 Four FDA-approved delivery methods offer flexibility based on patient preference and response.
Intramuscular injections of testosterone enanthate or cypionate at 75-100 mg weekly or 150-200 mg every 2 weeks normalize levels in 80-90% of men. Injections produce the most stable blood levels when dosed weekly, though the every-2-week protocol remains common. Subcutaneous pellets implanted every 3-6 months provide steady-state delivery without weekly dosing but require a minor office procedure.
Transdermal gels (1-2% formulation, 50-100 mg applied daily to shoulders or abdomen) offer convenience and avoid injection discomfort, but transfer risk to partners or children requires careful hand washing and covering application sites. Patches are less commonly prescribed due to skin irritation. Buccal tablets and nasal gels exist but have limited adoption.
Response timeline: most men notice libido and energy improvements within 3-6 weeks. Erectile function takes 3-6 months. Muscle mass and strength gains become apparent at 6-12 months with resistance training. Bone density increases require 12-24 months of consistent therapy.1
Monitoring includes testosterone levels at 3 months (target 400-700 ng/dL mid-cycle for injections, steady-state for gels), then every 6-12 months once stable. PSA and hematocrit at 3, 6, and 12 months catch the two most common side effects — prostate growth (though TRT doesn't cause cancer) and polycythemia (elevated red blood cell count). Hematocrit above 54% requires dose reduction or temporary cessation.
Fertility-Preserving Options
Men desiring fertility should avoid standard TRT, which suppresses sperm production by shutting down LH and FSH. Human chorionic gonadotropin (hCG) at 1500-5000 IU injected 2-3 times weekly mimics LH and stimulates endogenous testosterone production while maintaining spermatogenesis. Clomiphene citrate 25-50 mg daily blocks estrogen feedback at the pituitary, raising LH and FSH to boost natural testosterone output.3 Both options work only in secondary hypogonadism where the testes still respond to signals.
Lifestyle Modifications
Weight loss raises testosterone 50-100 ng/dL in overweight men by reducing aromatase activity and SHBG levels. Resistance training 3-4 times per week stimulates muscle protein synthesis and natural testosterone production. Sleep optimization matters — testosterone production peaks during deep sleep, and chronic sleep restriction (under 6 hours nightly) suppresses levels by 10-15%.
Medication review identifies suppressors: chronic opioid use, high-dose glucocorticoids, and certain antidepressants all lower testosterone. Switching or tapering these drugs when medically appropriate can restore normal levels without hormone therapy.
Addressing Underlying Causes
Secondary hypogonadism due to pituitary tumors, hyperprolactinemia, or Kallmann syndrome requires treating the primary condition first. Prolactinomas respond to dopamine agonists like cabergoline. Surgical resection or radiation targets non-functioning pituitary adenomas. Hemochromatosis treatment via phlebotomy can restore testicular function if caught before irreversible damage.
Transient causes like acute illness, severe calorie restriction, or post-operative states may resolve spontaneously within 3-6 months. Repeating labs after recovery avoids lifelong therapy for temporary suppression.
Treatment duration is lifelong for permanent causes like Klinefelter syndrome, testicular trauma, or age-related decline. Transient cases allow discontinuation once the underlying issue resolves. Annual reassessment ensures therapy remains necessary and effective.